• Guideline Summary
  • NGC:010430
  • 2014 May

Alemtuzumab for treating relapsing–remitting multiple sclerosis.

  • Guideline Summary
  • NGC:010284
  • 2014 Jan

Teriflunomide for treating relapsing–remitting multiple sclerosis.

  • Guideline Summary
  • NGC:010519
  • 2014 Aug

Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.

  • Guideline Summary
  • NGC:009075
  • 2012 Apr

Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis.

  • Expert Commentary

Comparison of Multiple Sclerosis Guidelines Underscores Need for Collaboration

  • Guideline Summary
  • NGC:010569
  • 2004 (revised 2014 Oct)

Multiple sclerosis: management of multiple sclerosis in primary and secondary care.

  • Guideline Summary
  • NGC:010418
  • 2013 Oct

Recommendations for drug therapies for relapsing-remitting multiple sclerosis.

  • Guideline Summary
  • NGC:010522
  • 2014

Occupational therapy practice guidelines for adults with neurodegenerative diseases.

  • Guideline Summary
  • NGC:009847
  • 1998 (revised 2012)

Dementia in the long term care setting.

  • Guideline Summary
  • NGC:011091
  • 2016 Jul 29

U.S. medical eligibility criteria for contraceptive use, 2016.

  • Guideline Summary
  • NGC:009361
  • 2004 Feb (revised 2012 Jan)

Nystagmus and oscillopsia.

  • Guideline Summary
  • NGC:009252
  • 2009 (revised 2012)

ACR Appropriateness Criteria® cranial neuropathy.